• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mpox (monkeypox) outbreak: epidemiological overview, 6 July 2023 - GOV.UK

Mary Wilson

Well-known member
UK HealthSecurity Agency

This epidemiological overview provides an update to the number of confirmed and highly probable mpox cases in England, Northern Ireland, Scotland and Wales.

Mpox is a zoonotic infection, caused by the monkeypox virus, that occurs mostly in West and Central Africa. Prior to 2022, cases diagnosed in the UK had been either imported from countries where mpox is endemic or contacts with documented epidemiological links to imported cases. Between 2018 and 2021, there had been 7 cases of mpox in the UK. Of these, 4 were imported, 2 were cases in household contacts, and one was a case in a health care worker involved in the care of an imported case. There was no documented community transmission in previous outbreaks.

The UK strategy for mpox control is to eliminate person-to-person transmission of mpox in the UK. Disease elimination is defined by the World Health Organization (WHO) European Region as the absence of indigenously acquired cases for a period of at least 3 months, in the presence of a well-performing surveillance system. Current epidemiological situation up to 30 June 2023

https://www.gov.uk/government/publi...outbreak-epidemiological-overview-6-july-2023
 
Back
Top